BioKnow

Best selling pharma medicines: ?? Eli Lilly: Mounjaro, Trulicity, Zepbound ?? Bristol-Myers Squibb: Eliquis, Revlimid, Opdivo ?? Novartis: Entresto, Cosentyx, Kesimpta ?? Roche: Ocrevus, Hemlibra, Vabysmo ?? AstraZeneca: Tagrisso, Imfinzi, Farxiga ?? AbbVie: Skyrizi, Humira, Rinvoq ?? Johnson & Johnson: Darzalex, Erleada, Stelara ?? Sanofi: Dupixent, Flublok, Quadracel ?? Merck: Keytruda, Gardasil 9, Lynparza ?? Pfizer: Paxlovid, Eliquis, Prevnar 20 This data underscores the significant influence of leading companies such as Johnson & Johnson, Novartis, Roche, Pfizer, and Sanofi in driving advancements in healthcare and treatment innovation. The global pharmaceutical market continues to expand, highlighting rapid developments and opportunities in drug delivery systems, precision medicine, and biopharmaceutical technologies. Source: Statpedia #pharmaceuticals #biopharma #biotech #pharma

In 2024, the FDA approved 50 new drugs, with over half targeting rare diseases (affecting fewer than 200K people in the U.S.) — are 'small markets' now offering the biggest opportunities for the pharmaceutical industry? Key highlights from this year’s approvals (resources linked in the comments): ?? Oncology leads with 30% of approvals, followed by significant progress in cardiology, dermatology, and hematology (~10% each). ?? 18 breakthrough therapies & 13 new indications for existing drugs. ?? Small molecules dominated (64%), with 16 protein-based therapies approved. ?? Notable firsts! A standout this year is Cobenfy — a novel schizophrenia treatment targeting muscarinic pathways, offering a fresh approach after decades of dopamine-focused therapies. Analysts predict peak sales over $3 billion! What trends stood out to you this year? Source/Credit @ Chris De Savi #biotech #biopharma #pharmaceuticals

The Night’s Watch: How Sleep Protects Against Neurodegeneration ???? Sleep isn't just rest—it's an active, essential process that safeguards brain health. A recent Neuron review by Samira Parhizkar & David M. Holtzman explores how sleep disturbances not only accompany neurodegenerative diseases but may also contribute to their onset and progression. Key takeaways: ?? Slow-wave sleep (SWS) helps clear metabolic waste and toxic proteins like amyloid-beta—key in Alzheimer’s disease (AD). ?? Sleep loss can increase inflammation and disrupt synaptic plasticity, potentially accelerating cognitive decline. ?? Genetics/ aging affect sleep architecture, influencing neurodegenerative risk. With dementia rates projected to double in the next 20 years, prioritizing sleep isn't just self-care, it's neuroprotection. How is your sleep hygiene? Full study, here: https://lnkd.in/eG78A887 #neurology #biotech #cns #biopharma

???????? ?????????? ???????????????? ?????????????????? ?? 300+ companies below. With the United States accounting for nearly half of the global pharmaceutical revenues and the world leader of CDMO it's fascinating to see who the main players are. Source: PharmaSource - link below too. #biopharma #CDMO #pharmaceuticals

2025 JPM Conference highlighted 5 key trends shaping healthcare: 1. Rising M&A Activity: Big pharma is increasingly acquiring biotechs to strengthen their pipelines, with over 100 investments exceeding $100M in 2024. 2. Health Policy Uncertainty: Regulatory changes, like drug pricing reforms and the Inflation Reduction Act of 2022, are creating uncertainty for the industry. 3. China’s Innovation Surge: Chinese biotechs, once minor players, now account for one-third of global licensing deals, marking a significant shift. 4. AI Revolutionizing Healthcare: AI is transforming drug development and clinical trials, with major collaborations accelerating biomedical discoveries. 5. CGTs Growth: Promising treatments for diseases like type 1 diabetes and Parkinson’s are advancing, but challenges remain in commercial access. We're witnessing the dawn of a new era in medicine. ?? Source: Forbes ?? Image credit: PharmaShots #pharmaceuticals #biotech #biopharma

?? 25K Strong! ?? BioKnow has officially reached 25,000 followers and we couldn't have done it without YOU. Thank you for being part of our journey, from engaging with our content, sharing your thoughts, and growing with us. Your support fuels our mission to make science and biology more accessible and exciting! What topics would you love to see more of? Drop your ideas in the comments! #bioknow #25k #biotech

FREE Biotech Newsletter: Your quick way to the latest breakthroughs... Here’s the proof: 90% of our subscribers report feeling more informed about biotech developments. Join a community of over 18,000 biotech enthusiasts who share insights and updates weekly! Join here: https://lnkd.in/decTJM6Q ?? Stay at the Forefront with critical updates and insider insights. ?? Don’t Miss a Beat in the rapidly evolving world of biotech! ?? Click Here Join Now and transform your understanding of biotech today! #Biotech #Biopharma #Pharmaceuticals

???????????? ?????????????? ???????????? ???????? ?? According to Fierce Pharma, Pfizer faces $17 billion in patent expirations later this decade. Between 2024 and 2027, the company expects to lose U.S. exclusivity for popular medications, including the blood thinner Eliquis, immunology treatment Xeljanz, rare disease therapy Vyndaqel, and oncology drugs such as Ibrance, Inlyta, and Xtandi. Source/Credit: Joanna Sadowska, PhD, EMBA - amazing work. #biopharma #pharmaceuticals #oncology

Top Pharma Companies by 2024 Pipeline Size ?? Check out the latest data from the Citeline Pharma R&D Review 2024, showcasing the top global pharmaceutical companies ranked by the number of drug candidates in their pipeline. ?? ?? Roche leads the pack with 218 drug candidates, followed closely by Pfizer at 205. ?? AstraZeneca, Lilly, and Bristol Myers Squibb round out the top five, all with impressive R&D pipelines. ?? Companies from the USA, Switzerland, France, UK, China, and Japan are all represented, highlighting the global nature of pharmaceutical innovation. Key insights: The USA dominates the list, with several companies leading innovation. Switzerland’s Roche holds the top position, demonstrating its continued investment in cutting-edge research. AstraZeneca and GSK represent the UK, showcasing the country's strong role in pharma R&D. China's presence with Hengrui signals growing innovation power in Asia. ?? The future of healthcare innovation looks brighter than ever as these companies work tirelessly on new treatments for various diseases. #biotech #biopharma #pharma

New Biologics Companies Launched?? 2024 saw exciting new compaies launched as shown below in the incredible lineup of new and emerging biologic companies in 2024, spanning cell therapy, gene therapy, RNA-based therapeutics, antibodies, and more. The innovation happening across these fields is driving the future of medicine, bringing groundbreaking treatments closer to patients. From next-gen protein therapies to cutting-edge bispecific antibodies, these companies are shaping the future of biotech. Which of these companies are you most excited about? Let’s discuss! Credit/Source: biopharmIQ - follow them! #oncology #biotech #celltherapy #biopharma